Population structure of gut Escherichia coli and its role in development of extra-intestinal infections

Iranian Journal of Microbiology

Volumn 2, Issue 2, 2010, Pages 59-72

  Katouli, Mohammad ^a  

^a UNIVERSITY OF THE SUNSHINE COAST   (Australia)

Author keywords

E.coli; Gut; Urinary tract infection; Virulence factors

Indexed keywords

ADHESIN; CYTOTOXIC NECROTIZING FACTOR 1; HEMOLYSIN; POLYSACCHARIDE; SIDEROPHORE; VIRULENCE FACTOR;

BACTERIAL MEMBRANE; BACTERIAL STRAIN; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FIMBRIA; GASTROINTESTINAL TRACT; HUMAN; INTESTINE FLORA; INTESTINE INFECTION; MENINGITIS; NONHUMAN; PATHOGENESIS; PHYLOGENY; POPULATION STRUCTURE; RESERVOIR; REVIEW; SEPTICEMIA; URINARY TRACT; URINARY TRACT INFECTION; VIRULENCE;

ESCHERICHIA COLI;

EID: 77957008791     PISSN: 20083289     EISSN: 20084447     Source Type: Journal    
DOI: None     Document Type: Review

References (129)

1. Guarner F, Malagelada J. Gut flora in health and disease. Lancet 2003; 360: 512-519.
2. Campbell NA, Reece JB. Biology, Pearson Education Inc, San Francisco, 2002.
3. O'Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO reports 2006; 7: 688-693.
4. Yu Q, Yang Q. Diversity of tight junctions (TJs) between gastrointestinal epithelial cells and their function in maintaining the mucosal barrier. Cell Biol Int 2009; 33: 78-82.
5. Baumgart DC, Dignass AU. Intestinal barrier function. Curr Opin Clin Nutr Metab Care 2002; 5: 685-694.
6. Salyers AA, Whitt DD. Bacterial pathogenesis: a molecular approach, ASM Press, Washington DC, 2002.
7. Dogi CA, Galdeano CM, Perdigón G. Gut immune stimulation by non pathogenic gram (+) and gram (-) bacteria. Comparison with a probiotic strain. Cytokine 2008; 41: 223-231.
8. Moal VL, Servin AL. The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota. Clin Micro Rev 2006; 19: 315-337.
9. MacFie J. Current status of bacterial translocation as a cause of surgical sepsis. Brit Med Bull 2004; 71: 1-11. (Pubitemid 40478218)
10. Stecher B, Hardt W. The role of microbioita in infectious disease. Trends Microbiol 2008; 16: 107-114.
11. Šmehilová M, Vlková E, Nevoral J, Flajšmanová K, Killer J, Rada V. Comparison of intestinal microflora in healthy infants and infants with allergic colitis. Folia Microbiol 2008; 53: 255-258.
12. Rodriguez-Siek KE, Giddings CW, Doetkott C, Johnson TJ, Fakhr MK, Nolan LK. Comparison of Escherichia coli isolates implicated in human urinary tract infection and avian colibacillosis. Microbiology 2005; 151: 2097-2110. (Pubitemid 40909051)
13. Guarner F, Perdigon G, Corthier G, Salminen S, Koletzki B, Morelli L. Should yoghurt cultures be considered probiotic? Brit J Nutr 2005; 93: 783-786. (Pubitemid 43899554)
14. Gavini F, Cayuela C, Antoine J, Lecoq C, Lefebvre B, Membré J, et al. Differences in the distribution of bifidobacterial and enterobacterial species in human faecal microflora of three different (children, adults, elderly) age groups. Microbial Ecol Health Dis 2001; 13: 40-45. (Pubitemid 32246581)
15. Saunier K, Doré J. Gastrointestinal tract and the elderly: functional food, gut microflora and healthy ageing. Digest Liver Dis 2002; 34: S19-S24.
16. Bailey MT, Engler H, Sheridan JF. Stress induces the translocation of cutaneous and gastrointestinal microflora to secondary lymphoid organs of C57BL/6 mice. J Neuroimmunol 2006; 171: 29-37.
17. Johnson JR, Moseley SL, Roberts PL, Stamm WE. Aerobactin and other virulence factor genes among strains of Escherichia coli causing urosepsis: association with patient characteristics. Infect Immun 1988; 56: 405-412.
18. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000; 66: 4555-4558.
19. Rijavec M, Müller-Premru M, Zakotnik B, Žgur-Bertok D. Virulence factors and biofilm production among Escherichia coli strains causing bacteraemia of urinary tract origin. J Med Microbiol 2008; 57: 1329-1334.
20. Johnson JR, Delavari P, Kuskowski M, Stell AL. Phylogenetic distribution of extraintestinal virulence-associated traits in Escherichia coli, J Infect Dis 2001; 183: 78-88. (Pubitemid 32043044)
21. Bingen-Bidois M, Clermont O, Bonacorsi S, Terki M, Brahimi N, Loukil C, et al. Phylogenetic analysis and prevalence or urosepsis strains of Escherichia coli bearing pathogenicity island-like domains. Infect Immun 2002; 70: 3216-3226. (Pubitemid 34564186)
22. Gordon DM, Clermont O, Tolley H, Denamur E. Assigning Escherichia coli strains to phylogenetic groups: multi-locus sequence typing versus the PCR triplex method. Environ Microbiol 2008; 10: 2484-2496.
23. Escobar-Páramo P, Clermont O, Blanc-Potard A, Bui H, Bouguénec CL, Denamur E. A specific genetic background is required for acquisition and expression of virulence factors in Escherichia coli. Mol Biol Evol 2004; 21: 1085-1094.
24. Johnson JR. Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev1991; 4: 80-128.
25. Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clin Microbiol Rev 1998; 11: 142-201.
26. Qadri F, Svennerholm AM, Faruque ASG, Sack RB. Enterotoxigenic Escherichia coli in developing countries: Epidemiology, microbiology, clinical features, treatment, and prevention. Clin Microbiol Rev 2005; 18: 465-483. (Pubitemid 40995112)
27. Petri WA, Miller M, Binder HJ, Levine MM, Dillingham R, Guerrant RL. Enteric infections, diarrhea, and their impact on function and development. J Clin Invest 2008; 118: 1277-1290. (Pubitemid 351500420)
28. Okeke IN, Nataro JP. Enteroaggregative Escherichia coli. Lancet Infect Dis 2001; 1: 304-313.
29. Bekal S, Brousseau R, Masson L, Prefontaine G, Fairbrother J, Harel J. Rapid identification of Escherichia coli pathotypes by virulence gene detection with DNA microarrays. J Clin Microbiol 2003; 41: 2113-2125. (Pubitemid 36576543)
30. Servin AL. Pathogenesis of Afa/Dr diffusely adhering Escherichia coli. Clin Microbiol Rev 2005; 18: 264-292.
31. Wold AE, Caugant DA, Lidin-Janson G, deMan P, Svanborg C. Resident colonic Escherichia coli strains frequently display uropathogenic characteristics. J Infect Dis 1992; 165: 46-52.
32. Nicolle LE. Short-term therapy for urinary tract infection: success and failure. Int J Antimicrob Agents 2008; 31S: S40-S45.
33. Scholes D, Hooton TM, Roberts PL, Stapleton AE, Gupta K, Stamm WE. Risk factors for recurrent urinary tract infection in young women, J Infect Dis 2000; 182: 1177-1182.
34. Foxman B, Barlow R, D'Arcy H, Gillespie B, Sobel JD. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol 2000; 10: 509-515.
35. Tartof SY, Solberg OD, Riley LW. Genotypic analyses of uropathogenic Escherichia coli based on fimH single nucleotide polymorphism (SNPs). J Med Microbiol 2007; 56: 1363-1369.
36. Harrington RD, Hooton TM. Urinary tract infection risk factors and genders. J Gender Specific Med 2000; 3: 27-34.
37. Czaja C, Stamm E, Stapleton A, Roberts P, Hawn T, Scholes D, et al. Prospective cohort study of microbial and inflammatory events immediately preceding Escherichia coli recurrent urinary tract infection in women. J Infect Dis 2009; 200: 528-536.
38. Moreno E, Andreu A, Pigrau C, Kuskowski MA, Johnson JR, Prats G. Relationship between Escherichia coli strains causing acute cystitis in women and the fecal E. coli population of the host. J Clin Microbiol 2008; 46: 2529-2534.
39. Schlager TA, Hendley JO, Bell AL, Whittam TS. Clonal diversity of Escherichia coli colonizing stools and urinary tracts of young girls. Infect Immun 2002; 70: 1225-1229.
40. Obata-Yasuoka M, Ba-Thein W, Tsukamoto T, Yoshikawa H, Hayashi H. Vaginal Escherichia coli share common virulence factor profiles, serotypes and phylogeny with other extraintestinal E. coli. Microbiology 2002; 148: 2745-2752.
41. Mabbett AN, Ulett GC, Watts RE, Tree JJ, Totsika M, Ong CY,et al. Virulence properties of asymptomatic bacteriuria Escherichia coli. Int J Med Microbio 2009; 299: 53-63.
42. Scholes D, Hooton TM, Roberts PL, Gupta K, Stapleton AE, Stamm WE. Risk factors associated with acute pyelonephritis in healthy women. Ann Intern Med 2005; 142: 20-27.
43. Snyder J, Haugen B, Lockatell CV, Maroncle N, Hagan EC, Johnson DE, et al. Coordinate expression of fimbriae in uropathogenic Escherichia coli. Infect Immun 2005; 73: 7588-7596. (Pubitemid 41587665)
44. Nicolle LE. Urinary tract pathogens in complicated infection and in elderly individuals. J Infect Dis 2001; 183: S5-S8. (Pubitemid 32174136)
45. Moreno E, Andreu A, Pérez T, Sabaté M, Johnson JR, Prats G. Relationship between Escherichia coli strains causing urinary tract infection in women and the dominant faecal flora of the same hosts. Epidemiol Infect 2006; 134: 1015-1023. (Pubitemid 44336377)
46. Mulvey MA, Schilling JD, Hultgren SJ. Establishment of a persistent Escherichia coli reservoir during acute phase of a bladder infection. Infect Immun 2001; 69: 4572-4579.
47. Alexander JW, Gianotti L, Pyles T, Carey MA, Babcock GF. Distribution and survival of Escherichia coli translocating from the intestine after thermal injury. Ann Surg 1990; 213: 558-566.
48. Jauréguy F, Carbonnelle E, Bonacorsi S, Clec'h C, Cacassus P, Bingen E, et al. Host and bacterial determinants of initial severity and outcome of Escherichia coli sepsis. Eur J Clin Microbiol Infect Dis 2007;13:854-862.
49. Johnson JR, Stell A. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 2000; 181: 261-272. (Pubitemid 30049057)
50. Jantunen ME, Saxen H, Lukinmaa S, Ala-Houhala M, Siitonen A. Genomic identity of pyelonephritogenic Escherichia coli isolated from blood, urine and faeces of children with urosepsis. J Med Microbiol 2001; 50: 650-652.
51. Reddy BS, Macfie J, Gatt M, Macfarlane-Smith L, Bitzopoulou K, Snelling AM. Commensal bacteria do translocate across the intestinal barrier in surgical patients. Clin Nutr 2007; 26: 208-215.
52. Ramos NL, Saayman ML, Chapman TA, Tucker JR, Smith HV, Faoagali J, et al. Genetic relatedness and virulence gene profiles of Escherichia coli strains isolated form septiaemic and uroseptic patients. Eur J Clin Microbiol Infect Dis 2010; 29: 15-23.
53. Kaper JB, Nataro JP, Mobley HLT. Pathogenic Escherichia coli Nat Rev Microbiol 2004; 2: 123-140.
54. Bingen E, Bonacorsi S, Brahimi N, Denamur E, Elion J. Viruelnce patterns of Escherichia coli K1 strains associated with neonatal meningitis. J Clin Microbiol 1997; 35: 2981-2982. (Pubitemid 27452449)
55. Stins MF, Badger J, Kim KS. Bacterial invasion and transcytosis in transfected human brain microvascular endothelial cells. Microbial Path 2001; 30: 19-28. (Pubitemid 32113477)
56. Holden NJ, Gally DL, Switches, cross-talk and memory in Escherichia coli adherence. J Med Microbiol 2004; 53: 585-593.
57. Martinez JJ, Mulvy MA, Schilling JD, Pinker JS, Hultgren SJ. Type 1 pilus-mediated bacterial invasion of bladder epithelial cells EMBO J 2000; 19: 2803-2812.
58. Jones CH, Pinkner JS, Roth R, Heuser J, Nicholes AV, Abraham SN, et al. FimH adhesin of type 1 pili is assembled into a fibrillar tip structure in the Enterobacteriaceae. Proc Natl Acad Sci 1995; 92: 2081-2085.
59. Dhakal BK, Kulesus RR, Mulvey MA. Mechanisms and consequences of bladder cell invasion by uropathogenic Escherichia coli. Eur J Clin Invest 2008; 38: 2-11.
60. Abraham SN,. Shin JS, Malaviya R. Type 1 fimbriated Escherichia coli - Mast cell interactions in cystitis. J Infect Dis 2001; 183: S51-S54.
61. Wright KJ, Seed PC, Hultgren SJ. Development of intracellular bacterial communitities of uropathogenic Escherichia coli depends on type 1 pil. Cell Microbiol 2007; 9: 2230-2241.
62. Pak J, Pu Y, Zhang Z, Hasty DL, Wu X. Tamm-Horsfall protein binds to type 1 fimbriated Escherichia coli and prevents E. coli from binding to uroplakin Ia and Ib receptors. J Biol Chem 2001; 276: 9924-9930.
63. Holden N, Blomfield IC, Uhlin BE, Totsika M, Kulasekara DH, Gally DL. Comparative analysis of FimB and FimE recombinase activity. Microbiology 2007; 153: 4138-4149.
64. Holden NJ, Totsika M, Mahler E, Roe AJ, Catherwood K, Lindner K, et al. Demonstration of regulatory cross-talk between P fimbriae and type 1 fimbriae in uropathogenic Escherichia coli. Microbiology 2006; 152: 1143-1153.
65. Xia Y, Gally D, Forsmann-Semb K, Uhlin BE. Regulatory cross-talk between adhesin operons in Escherichia coli: inhibition of type 1 fimbriae expression by the papB protein. EMBO J 2000; 19: 1450-1457. (Pubitemid 30182152)
66. Holden NJ, Uhlin BE, Gally DL. PapB paralogues and their effect on the phase variation of type 1 fimbriae in Escherichia coli. Mol Microbiol 2001; 42: 319-330.
67. Gunther IV NW, Lockatell V, Johnson DE, Mobley HLT. In vivo dynamics of type 1 fimbria regulation in uropathogenic Escherichia coli during experimental urinary tract infection. Infect Immun 2001; 69: 2838-2846. (Pubitemid 32332172)
68. Teng C, Xie Y, Shin S, Cello FD, Paul-Satyaseela M, Cai M, et al. Effects of impA deletion on expression of type 1 fimbriae in Escherichia coli K1 strain RS218 and on the association of E. coli with human brain microvascular endothelial cells. Infect Immun 2006; 74: 5609-5616. (Pubitemid 44484544)
69. Xie Y, Yao Y, Kolisnychenko V, Teng C, Kim KS. HbiF regulated type 1 fimbriation independently of FimB and FimE. Infect Immun 2006; 74: 4039-4047. (Pubitemid 43993336)
70. Sokurenko EV, Courtney HS, Maslow J, Siitonen A, Hasty DI. Quantitative differences in adhesiveness of type 1 fimbriated Escherichia coli due to structural differences in fimH genes. J Bacteriol 1995; 177: 3680-3686.
71. Ronald LS, Yakovenko O, Yazvenko N, Chattopadhyay S, Aprikian P, Thomas W E, et al. Adaptive mutations in the signal peptide of the type 1 fimbrial adhesin of uropathogenic Escherichia coli. Proc Natl Acad Sci 2008; 105: 10937-10942.
72. Martindale J, Stround D, Moxon ER, Tang CM. Genetic analysis of Escherichia coli K1 gastrointestinal colonization. Mol Microbiol 2000; 37: 293-1305.
73. Tullus K, Kühn I, Ørskov I, Ørskov F, Möllby R. The importance of P and type 1 fimbriae for the persistence of Escherichia coli in the human gut. Epidemiol Infect 1992; 108: 415-421.
74. Wold AE, Thorssén M, Hull S, Svanborg Edén C. Attachment of Escherichia coli via mannose- or Galα1→ 4Galβ- containing receptors to human colonic epithelial cells. Infect Immun 1988; 56: 2531-2537.
75. Hamrick TS, Harris SL, Spears PA, Havell EA, Horton JR, Russell PW, et al. Genetic characterization of Escherichia coli type 1 pilus adhesin mutants and identification of a novel binding phenotype. J Bacteriol 2000; 182: 4012-4021.
76. Goetz MB, Kuriyama SM, Silverblatt FJ. Phagolysosome formation by polymorphonuclear neutrophilic leukocytes after ingestion of Escherichia coli that express type 1 pili. J Infec Dis 1987; 156: 229-233.
77. Bollinger RR, Everett ML, Palestrant D, Love SD, Lin SS, Parker W. Human secretory immunoglobulin A may contribute to biofilm formation in the gut. Immunology 2003; 109: 580-587. (Pubitemid 36930175)
78. Plos K, Connell H, Jodal U, Marklund B, Mårild S, Wettergren B, et al. Intestinal carriage of P fimbriated Escherichia coli and the susceptibility to urinary tract infection in young children. J Infect Dis 1995; 171: 625-631.
79. Nowrouzian FL, Adlerberth I, Wold AE. Enhanced persistence in the colonic microbiota of Escherichia coli strains belonging to phylogenetic group B2: role of virulence factors and adherence to colonic cells. Microbes Infect 2006; 8: 834-840.
80. Nowrouzian FL, Adlerberth I, Wold AE. P fimbriae, capsule and aerobactin characterize colonic resident Escherichia coli. Epidemiol Infect 2001; 126: 11-18.
81. Snyder JA, Haugenn BJ, Buckles EL, Lockatell CV, Johnson DE, Donnenberg MS, et al. Transcriptome of uropathogenic Escherichia coli during urinary tract infection. Infect Immun. 2004; 72: 6373-6381. (Pubitemid 39425418)
82. Leffler H, Svanborg Edén C. Chemical identificaiton of a glycosphingolipid receptor for Escherichia coli attaching to human urinary tract epithelial cells and agglutinating human erythrocytes. FEMS Microbiol Lett 1980; 8: 127-134. (Pubitemid 10057684)
83. Fischer H, Ellström P, Ekström K, Gustafsson L, Gustafsson M, Svanborg C. Ceramide as a TLR4 agonist; A putative signalling intermediate between sphingolipid receptors for microbial ligands and TLR4. Cell Microbiol 2007; 9: 1239-1251. (Pubitemid 46547141)
84. Bergsten G, Wullt B, Svanborg C. Echerichia coli, fimbriae, bacterial persistence and host response induction in the human urinary tract. Int J Med Microbiol 2005; 296: 487-502. (Pubitemid 41225460)
85. Hull RA, Rudy DC, Donovan WH, Wieser IE, Stewart C, Darouiche RO. Virulence properties of Escherichia coli 83972, a prototype strain associated with asymptomatic bacteriuria. Infect Immun 1999; 67: 429-432.
86. Nowrouzian FL, Wold AE, Alderberth I. Escherichia coli strains belonging to phylogenetic group B2 have superior capacity to persist in the intestinal microflora of infants. J Infect Dis 2005; 191: 1078-1083.
87. Bagger-Skjøt L, Sandvang D, Frimodt-Møller N, Lester CH, Olsen KEP, Porsbo LJ, et al. Association between antimicrobial resistance and virulence genes in Escherichia coli obtained from blood and faeces. Scand J Infect Dis 2007; 39: 724-727.
88. Nowrouzian FL, Wold AE, Adlerberth I. P fimbriae and aerobactin as intestinal colonization factors for Escherichia coli in Pakistani infants. Epidemiol Infect 2001; 126: 19-23. (Pubitemid 32266423)
89. Schlager TA, Whittam TS, Hendley JO, Bhang JL, Wobbe CL, Stapleton A. Variation in frequency of the virulence-factor gene in Escherichia coli clones colonizing the stools and urinary tracts of healthy prepubertal girls. J Infect Dis 2003; 188: 1059-1064. (Pubitemid 37268258)
90. Zhang L, Foxman B, Marrs C. Both urinary and rectal Escherichia coli isolates are dominated by strains of phylogenetic group B2. J Clin Microbiol 2002; 40: 3951-3955. (Pubitemid 35285772)
91. Johnson JR, Delavari P. Concurrent fecal colonization with extraintestinal pathogenic Escherichia coli in a homosexual man with recurrent urinary tract infection and in his male sex partner. Clin Infect Dis 2002; 35:65-68.
92. Björnham O, Nilsson H, Andersson M, Schedin S. Physical properties of the specific PapG-galabiose binding in E. coli P pili-mediated adhesion. Eur Biophys J 2009; 38:245-254.
93. Tseng C, Huang J, Wang M, Wu A, Ko W, Chen W, et al. PapG II adhesin in the establishment and persistence of Escherichia coli infection in mouse kidneys. Kidney Int 2007; 71: 764-770. (Pubitemid 46624021)
94. Zhano L, Chen X, Zhu X, Yang W, Dong L, Xu X, et al. Prevalence of virulence factors and antimicrobial resistance of uropathogenic Escherichia coli in Jiangsu province (China). Urology 2009; 74; 702-707.
95. Lane MC, Mobley M. Role of P-fimbrial-mediated adherence in pyelonephritis and persistence of uropathogenic Escherichia coli (UPEC) in the mammalian kidney. Kidney Int 2007; 72: 19-25.
96. Otto G, Magnusson M, Svensson M, Braconier J, Svanborg C. pap genotype and P fimbrial expression in Escherchia coli causing bacteremic and nonbacteremic febrile urinary tract infection. Clin Infect Dis 2001; 32: 1523-1531.
97. Mahmood A, Engle MJ, Hultgren SJ, Goetz GS, Dodson K, Alpers DH. Role of intestinal surfactant-like participles as a potential reservoir of uropathognic Escherichia coli. Biochim Biophys Acta 2000; 1523: 49-55.
98. Cavalieri SJ, Snyder IS. Effect of Escherichia coli α-haemolysin on human peripheral leukocyte viability in vitro. Infect Immun 1982; 36: 455-461.
99. Goebel W, Hedgpeth J. Cloning and functional characterization of the plasmid-encoded hemolysin determinant of Escherichia coli. J Bacteriol 1982; 151: 1290-1298.
100. Lebek G, Gruenig HM. Relation between the hemolytic property and iron metabolism in Escherichia coli. Infect Immun 1985; 50: 682-686. (Pubitemid 16216859)
101. Siitonen A. Escherichia coli in fecal flora of healthy adults: Serotypes, P and type 1C fimbriae, non-P manose-resistant adhesins, and hemolytic activity. J Infect Dis 1992; 166: 1058-1065.
102. Fiorentini C, Donelli G, Matarrese P, Fabbri A, Paradisi S, Boquet P. Escherichia coli cytotoxic necrotizing factor 1: evidence for induction of actin assembly by constitutive activation of the p21 Rho GTPase. Infect Immun 1995; 63: 3936-3944.
103. Mills M, Meysick KC, O'Brien AD. Cytotoxic necrotizing factor type 1 of uropathogenic Escherichia coli kills cultured human uroepithelial 5637 cells by an apoptotic mechanism. Infect Immun 2000; 68: 5869-5880.
104. Rippere-Lampe KE, O'Brien AD, Conran R, Lockman HA. Mutation of the gene encoding cytotoxic necrotizing factor type 1 (cnf 1) attenuates the virulence of uropathogenic Escherichia coli. Infect Immun 2001; 69: 3954-3964.
105. Hertting O, chromek M, Slamová Z, Kádas L, Söderkvist M, Vaninumäe I, et al. Cytotoxic necrotizing factor 1 (CNF1) induces an inflammatory response in the urinary tract in vitro but not in vivo. Toxicon 2008; 51: 1544-1547.
106. Rippere-Lampe KE, Lang M, Ceri H, Olson M, Lockman HA, O'Brien AD. Cytotoxic necrotizing factor type 1-positive Escherichia coli causes increased inflammation and tissue damage to the prostate in a rat prostatitis model. Infect Immun 2001; 69: 6515-6519. (Pubitemid 32885218)
107. Johnson DE, Drachenberg C, Lockatell CV, Island MD, Warren JW, Donnenberg MS. The role of cytotoxic necrotizing factor-1 in colonization and tissue injury in a murine model of urinary tract infection. FEMS Immunol Med Microbiol 2000; 28: 37-41. (Pubitemid 30184870)
108. Siqueira AK, Ribeiro MG, Leite DS, Tiba MR, Moura C, Lopes MD, et al. Virulence factors in Escherichia coli strains isolated from urinary tract infection and pyometra cases and from feces of healthy dogs. Res Vet Sci 2009; 86: 206-210.
109. Brauner A, Katouli M, Tullus K, Jacobson SH. Production of cytotoxic necrotizing factor, verocytotoxin and haemolysin by pyelonephritogenic Escherichia coli. Eur J Clin Microbiol Infect Dis 1990; 9: 762-767.
110. Litwin CM, Calderwood SB. Role of iron in regulation of virulence genes. Clin Microbiol Rev 1993; 6: 137-149.
111. Kumar S, Bandyopadhyay U. Free heme toxicity and its detoxification systems in human. Toxicol Lett 2005; 157: 175-188.
112. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T. IL-6 mediated hypferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004; 113:1271-1276. (Pubitemid 39069926)
113. deBrito BG, Leite DS, Linhares REC, Vidotto MC. Virulence-associated factors of uropathogenic Escherichia coli strains isolated from pigs. Vet Microbiol 1999; 65: 23-132.
114. Opal SM, Cross AS, Gemski P, Lyhte LW. Aerobactin and α-hemolysin as virulence determinants in Escherichia coli isolated from human blood, urine, and stool. J Infect Dis 1990; 161: 794-796. (Pubitemid 20120244)
115. E. coli, J Infect Dis 2002; 185: 1521-1524.
116. Maruvada R, Blom AM, Prasadaro NV. Effects of complement regulators bound to Escherichia coli K1 and Group B Streptococcus on the interaction with host cells. Immunology 2008; 124: 265-276.
117. Herías MV, Midtvedt T, Hanson LA, Wold AE. Escherichia coli K5 capsule expression enhances colonization of the large intestine in the gnotobiotic rat. Infect Immun 1997; 65: 531-536. (Pubitemid 27053221)
118. Marrs CF, Zhang L, Tallman P, Manning SD, Somsel P, Raz P, et al. Variations in 10 putative uropathogen virulence genes among urinary, faecal and peri-urethral Escherichia coli. J Med Microbiol 2002; 51: 138-142. (Pubitemid 34136749)
119. Katouli M, Brauner A, Kaijser B, Muratov V, Haghighi LK, Möllby R. Virulence characteristics of Escherichia coli strains causing acute cystitis in young adults in Iran. J Infection 2005; 50: 312-321. (Pubitemid 40533368)
120. Duriez P, Clermont O, Bonacorsi S, Bingen E, Chaventre A, Elion J, et al. Commensal Escherichia coli isolates are phylogenetically distributed among geographically distinct human populations. Microbiology 2001; 147: 1671-1676. (Pubitemid 32544832)
121. Moreno E, Johnson JR, Pérez T, Prats G, Kuskowski MA, Andreu A. Structure and urovirulence characteristics of the fecal Escherichia coli population among healthy women. Microbes Infect 2009; 11: 274-280.
122. Kuhar I, Grabnae M, Žgur-Bertok D. Virulence determinants of uropathogenic Escherichia coli in fecal strains from intestinal infections and healthy individuals. FEMS Microbiol Lett 1998; 164: 243-248. (Pubitemid 28321540)
123. Ron EZ. Host specificity of septicemic Escherichia coli: human and avian pathogens. Curr Opin Microbio 2006; 1 9: 28-32.
124. Skyberg JA, Johnson TJ, Johnson JR, Clabots C, Logue CM, Nolan LK. Acquisition of avian pathogenic Escherichia coli plasmids by a commensal E. coli isolate enhances its ability to kill chicken embryos, grow in human urine, and colonize the murine kidney. Infect Immun 2006; 74: 6287-6292. (Pubitemid 44657409)
125. MacFie J, O'Boyle C, Mitchell CJ, Buckley PM, Johnstone D, Sudworth P. Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity. Gut 1999; 45: 223-228.
126. Finfer S, Bellomo R, Lipman J, French C, Dobb G, Myburgh J. Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units. Intensive Care Med 2004; 30: 589-596.
127. Bian A, Brauner A, Li Y, Normark S. Expression of and cytokine activation by Escherichia coli curli fibers in human sepsis. J Infect Dis 2000; 181: 602-612.
128. Johnson JR, Owens K, Gajewski A, Kuskowski MA. Bacterial characteristics in relation to clinical source of Escherichia coli isolates from women with acute cystitis or pyelonephritis and uninfected women. J Clin Microbiol 2005; 43: 6064-6072. (Pubitemid 43100662)
129. Blanco M, Blanco J E, Alonso M P, Blanco J. Virulence factors and O groups of Escherichia coli isoaltes from patients with acute pyelonephritis, cystitis and asymptomatic bacteriuria. Eur J Epidemiol 1996; 12: 191-198. (Pubitemid 26226430)